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Abstract. Background: Child-Pugh score is used to predict the poor prognosis of liver 
cirrhosis patients. The study objectives analyzed differences in inflammatory parameters of 
Child-Pugh B and Child-Pugh C of liver cirrhosis with hepatorenal syndrome. Method: 
Desain's study is cross-sectional in liver cirrhosis patients with hepatorenal syndrome.  This 
research was approved by the Health Research Ethics Commission FK USU / RSUP H. Adam 
Malik Medan and meets the criteria of inclusion or exclusion. Diagnosis of Liver cirrhosis 
Child-Pugh B and Child-Pugh C score is done by clinical examination, laboratory, and 
ultrasound, CT scan, MRI. The hepatorenal syndrome was diagnosed using Criteria 
International Ascites Club, 2007. Results: The sample number of this study was 26 liver 
cirrhosis with hepatorenal syndrome patients consisting of Child-Pugh B patients 9 patients 
and Child-Pugh C patients 17  patients. The comparison between Child-Pugh B and Child-
Pugh C has significant differences in leukocyte, Na, Cl, SGOT, and CTP. There is a 
significant correlation between CTP and leukocytes, platelets, Cl, creatinine, GFR, albumin, 
total bilirubin, and glued bilirubin. Conclusion: There is no clear difference in the 
inflammatory parameters of the Child-Pug B and Child-Pug C scores in liver cirrhosis with 
hepatorenal syndrome.  
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Abstrak. Latar belakang: Skor Child-Pugh digunakan untuk memprediksi prognosis yang 
buruk pasien sirosis hati. Tujuan penelitian menganalisis perbedaan parameter peradangan 
dari skor  Child-Pugh B dan Child-Pugh C sirosis hati dengan sindrom hepatorenal. Metode:  
Desain studi adalah potong lintang pada pasien sirosis hati dengan sindrom hepatorenal. 
Penelitian ini disetujui oleh Komisi Etik Penelitian Kesehatan FK USU/RSUP H. Adam 
Malik Medan dan memenuhi kriteria inklusi atau ekslusi. Diagnosis  skor Liver cirrhosis 
Child-Pugh B dan Child-Pugh C dilakukan dengan pemeriksaan klinis, laboratorium dan 
USG, CT scan, MRI. Sindroma hepatorenal didiagnosis menggunakan Criteria International 
Ascites Club, 2007. Hasil: Jumlah sampel penelitian ini adalah 26 pasien sirosis hati dengan 
sindrom hepato renal yang terdiri dari pasien Child-Pugh B 9 pasien dan pasien Child-Pugh 
C 17 pasien. Perbandingan antara Child-Pugh B dan Child-Pugh C memiliki perbedaan 
signifikan pada leukosit, Na,Cl, SGOT dan CTP. Ada korelasi yang signifikan antara CTP 
dengan leukosit, trombosit, Cl, kreatinin, GFR, Albumin, bilirubin total dan bilirubin direk. 
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Kesimpulan: Tidak ada perbedaan yang jelas dalam parameter peradangan dari skor Child-
Pug B dan Child-Pug C pada sirosis hati dengan sindrom hepatorenal. 
Kata kunci: Hati-Sirosis, Hepato-Renal-Syndrome, Skor Child-Pugh, CTP 
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1 Introduction 
Reviewing of literature, there are limited data regarding the use of the Child-Pugh score to predict 
medical utilization in patients with acute hepatitis. The Child-Pugh score was noted to predict 
poor prognosis in patients with cirrhosis.[1] or hepatocellular carcinoma [2]. Zhu et al  [3] found 
that the Child-Pugh score was an independent determinant for the length of hospital stay (LOHS) 
after hepatectomy in patients with hepatocellular carcinoma. The Child-Pugh score had positive 
impacts on both the medical expense and the LOHS. Higher Child-Pugh scores were referred to 
hepatic decompensation that might be explained by the higher medical expense the was paid and 
LOHS was also longer in these patients [4] Liver cirrhosis is classified into two stages: 
compensated and decompensated liver cirrhosis. Decompensated cirrhosis is characterized by the 
presence of ascites, variceal bleeding, and hepatic encephalopathy, with a difference of 2 years of 
survival versus 12 years of the compensated disease. [5]  The main cause of the transition from a 
compensated to a decompensated stage is portal hypertension. [6] The occurrence of further 
decompensation (i.e. refractory ascites, spontaneous bacterial peritonitis, hepatorenal syndrome 
(HRS), and recurrence of hepatic encephalopathy and variceal bleeding) shortens the survival. 
The hepatorenal syndrome is one characterized by a very poor prognosis, [7] therefore it is 
necessary to identify it early and understand the syndrome so other causes of renal failure can be 
excluded so a medical treatment or transplant can start as soon as possible.  
Modified Child Turcotte-Pugh (CTP) score, by adding creatinine, performed similarly to model 
for end-stage liver disease score. Hepatic encephalopathy and hyponatremia (as an index of 
ascites), both components of CTP score, add to the prognostic performance of the model for end-
stage liver disease score. [8] Our study was a pilot study and was conducted to find out the 
correlation between medical utilization and the Child-Pugh score. 
The study objectives compared inflammatory and electrolyte parameters between Child-Pugh B 
and Child-Pugh C in liver cirrhosis patients with hepatorenal syndrome. 
2 Method 
The study is a cross-sectional design of 26 liver cirrhosis with hepatorenal syndrome patients. 
The studies are approved by the Ethics Commission for Health Research FK USU / RSUP H. 
Adam Malik Medan and meet the criteria of inclusion or exclusion. Diagnosis of Liver cirrhosis 
is carried out by clinical, laboratory and examinations of ultrasound, CT scan, MRI, Hepatorenal 
Journal of Endocrinology, Tropical Medicine, and Infectiouse Disease (JETROMI) Vol. 03, No. 1, 2021         14                                                          
Syndrome diagnosed using the Criteria International Ascites Club, 2007, [9] Neutrophil Gelatin 
is associated Lipocalin (NGAL) urine using Elisa (Human Lipocalin-2/NGAL Immunoassay, 
R&D System Inc), kidney function using Cockcroft and Gaul Formula, CTP using the calculator. 
3 Data Analysis  
Data univariate analysis is presented descriptively, displaying average data and standard 
deviations. Test normality of data using the Shapiro Wilk test. The bivariate analysis uses a T-
independent test if data is distributed normally. If data is not distributed normally used the Mann-
Whitney test. Test Pearson correlation when distributed data is normal, and use spearman 
correlation if data is not distributed normally. Analysis using computer programs SPSS 23 
(Statistical Product and for Social Sciences) and confidence intervals of 95%, where p< 0.05. 
4 Results 
The sample number of this study was 26  patients liver cirrhosis with hepato renal syndrome 
consisting of Child-Pugh B 9 patient and Child-Pugh C 17 patients (table 1). 
Table 1  Baseline Data of Patients 
 
  
In table 2, the comparison between Child-Pug B and Child-Pug C has significant differences in 
leucocyte, Na,Cl, SGOT  and CTP. 
Parameter N=26, MeanSD 
Age, yr 57.508.91 
BW, Kg 59.035.98 
Hb, gr/dL 9.041.20 
Leukosit, sell/mm3 8128.072935.01 
Trombosit,  sell/mm3 139730.7639704.46 
Na, mEq/L 130.808.15 
K,  mEq/L 40.5613.23 
Cl,  mEq/L 98.738.96 
Ureum, mg/dL 84.2834.01 
Creatinin,  mg/dL 2.450.61 
GFR, mL/min/1.73 m2 28.5310.31 
NGAL, ng/ml. 13078.344513.94 
Albumin,  mg/dL 24.929.09 
SGOT,  µ/l 110.9686.12 
SGPT,  µ/l 66.8449.79 
Bilirubin Total, mg/dL 6.067.28 
Bilirubin Direk,  mEq/L 4.065.56 
INR 1.540.44 
CTP 10.111.36 
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Table 2 The Comparison Parameters between Child-Pug B and Child-Pug C in Liver  

















                  
*p<0.05; **p<0.01 
 
In table 3, there was a significant correlation between CTP and leukocytes, thrombosit, Cl, 
















Parameter Child-Pug B                  
n=9, meanSD 
Child-Pug C             
n=17, meanSD 
p 
Age, yr 59.338.74 56.529.11 0.457 
BW, Kg 56.663.84 60.296.62 0.145 
Hb, gr/dL 9.520.83 8.791.31 0.147 
Leukosit, sell/mm3 5891.112268.11 9312.352565.68 0.003* 
Trombosit,  sell/mm3 126555.5529698.95 146705.8843276.38 0.225 
Na, mEq/L 136.773.11 127.648.27 0.004* 
K,  mEq/L 40.666.16 40.5115.95 0.978 
Cl,  mEq/L 103.552.78 96.1710.07 0.043* 
Ureum, mg/dL 71.5535.60 91.0232.16 0.170 
Creatinin,  mg/dL 2.410.67 2.470.59 0.805 
GFR, mL/min/1.73 m2 26.667.36 29.5211.67 0.512 
NGAL, ng/ml. 11455.002785.20 13937.765068.65 0.188 
Albumin,  mg/dL 27.554.74 23.5210.58 0.292 
SGOT,  µ/l 55.3345.59 140.4188.82 0.013* 
SGPT,  µ/l 51.4441.34 75.0053.05 0.259 
Bilirubin Total, mg/dL 2.001.23 8.218.23 0.035 
Bilirubin Direk,  mEq/L 1.772.37 5.276.40 0.130 
INR 1.430.44 1.600.44 0.352 
CTP 8.550.52 10.940.82 0.001** 
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Table 3 Correlation between CPT with inflammatory parameters of liver cirrhosis with 



















The child-Pugh score was firstly proposed by Child and Turcotte to predict the operative risk in 
patients undergoing portosystemic shunt surgery for variceal bleeding. The primary version of 
the Child-Pugh score included ascites, hepatic encephalopathy (HE), nutritional status, total 
bilirubin, and albumin. Pugh et al [10] modified the Child–Pugh classification by adding 
prothrombin time or an international normalized ratio (INR) and removing nutritional status. The 
Child-Pugh score has been widely used to assess the severity of liver dysfunction in clinical work. 
Model for end-stage liver disease (MELD) score was initially created to predict the survival of 
patients undergoing transjugular intrahepatic portosystemic shunts (TIPS). [11] The primary 
version of the MELD score included the etiology of liver cirrhosis, but this variable was 
unnecessary. [12] The present version of the MELD score incorporated only 3 objective variables, 
including total bilirubin, creatinine, and INR. Currently, it has been used to rank the priority of 
liver transplantation (LT) candidates. Child-Pugh and MELD scores have been widely used to 
predict the outcomes of cirrhotic patients. However, they have some drawbacks. First, 2 variables 
(i.e. ascites and HE) included in the Child-Pugh score are subjective and may be variable 
according to the physicians' judgment and the use of diuretics and lactulose. Second, INR, which 
Parameter r p 
Age, yr 0.340 0.089 
BW, Kg 0.019 0.927 
Hb, gr/dL -0.185 0.366 
Leukosit, sell/mm3 -0.436* 0.026* 
Trombosit,  sell/mm3 -0.425* 0.030* 
Na, mEq/L 0.334 0.095 
K,  mEq/L 0.047 0.820 
Cl,  mEq/L 0.677** 0.001** 
Ureum, mg/dL -0.287 0.155 
Creatinin,  mg/dL 0.459* 0.018* 
GFR, mL/min/1.73 m2 -.561** 0.003* 
NGAL, ng/ml. 0.201 0.324 
Albumin,  mg/dL 0.571** 0.002* 
SGOT,  µ/l 0.382 0.054 
SGPT,  µ/l 0.047 0.820 
Bilirubin Total, mg/dL 0.677** 0.001** 
Bilirubin Direk,  mEq/L 0.571** 0.002* 
INR 0.382 0.054 
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is one component of both Child-Pugh and MELD scores, does not sufficiently reflect 
coagulopathy and consequently liver function in liver cirrhosis. [13] Third, there is an 
interlaboratory variation in INR value. [14] 
The routine use of these classifications has revealed some problems. First, both the degree of 
ascites and encephalopathy are subjective assessments evaluated by physical examination alone. 
The widespread use of ultrasonography has led to more sensitive detection of ascites, but it is 
unclear how ascites diagnosed by ultrasonography alone is being categorized by various authors. 
Hepatic encephalopathy (HE) is often assessed by psychometric testing or slowing of frequency 
on electroencephalography (EEG). It is not clear how these abnormalities are fitted into CTP 
classification. Secondly, both ascites and HE can be influenced by therapy such as diuretics, 
albumin infusion, and lactulose and it is not clear if ascites and HE are scored at their best, or 
worst, or independent of a specific therapy. As regards the continuous variables in the CTP 
classification, they are categorized with arbitrary cut-off points. Thus, patients with a bilirubin of 
55 um have a better prognosis than those with a bilirubin of 250 um; in the CTP classification, 
both these patients have the same score of severity for bilirubin concentration ('the ceiling effect'). 
Changes in bilirubin concentration with specific therapy such as ursodeoxycholic acid (for which 
improvements are in doubt) are difficult to interpret using CTP classification [15]. A similar 
problem exists for serum albumin so that the CTP classification does not differentiate between 
patients with albumin of 17 g/L vs. 25 g/L ('the floor effect').  
The International Normalized Ratio (INR) now overcomes this using a standardized 
thromboplastin reagent. The conversion from INR to PT and vice versa using a nomogram is not 
used routinely and INR has not been incorporated into the CTP score. Although it would seem 
sensible to use INR, it should be remembered that INR was designed to standardize the 
anticoagulation effect of warfarin and not to evaluate the severity of the liver disease. As a result, 
INR may not be valid to assess liver impairment, [16] despite its use in a model for end-stage 
liver disease (MELD) scoring.  
Partly due to the grading system, the CTP classification does not distinguish the 'mild' grade C 
from the severe grade C patient with sufficient clinical discrimination. Moreover, it does not 
include a measure of renal function, which is a well-established prognostic marker interpret using 
CTP classification. Exists for serum albumin so that the CTP classification does not differentiate 
between patients with albumin of 17 g/L vs. 25 g/L ('the floor effect'). The increased use of 
intravenous albumin if given close to an assessment may further complicate the interpretation. 
This model was found to be superior to both CTP classification and score in predicting survival, 
especially in patients with CTP class B with impaired renal function. A similar problem published 
an article on cirrhosis, as well as in acute liver disease. [17] 
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In this study, the difference in important inflammatory parameters between the levels of Child-
Pug B and Child-Pug C was not significant, nor the correlation of CPT parameters with important 
inflammatory parameters as a prognostic factor.  
6 Conclusion 
There is no clear difference in inflammatory parameters of Child-Pug B and Child-Pug C scores 
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